首页> 美国卫生研究院文献>Cancers >The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response
【2h】

The Role of Colorectal Cancer Stem Cells in Metastatic Disease and Therapeutic Response

机译:结直肠癌干细胞在转移性疾病和治疗反应中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colorectal cancer is the third-leading cause of cancer related mortality in the United States. The intricate molecular mechanisms involved in the regenerative process of the normal intestine and the identity of putative somatic intestinal stem cells have become clear. In parallel with this, experiment evidence has emerged supporting the century old hypothesis that solid tumor initiation, progression, chemoresistance and recurrence is the result of a small population of cancer cells with self-renewal and pluripotency capabilities. These “cancer stem cells” (CSCs) present a unique opportunity to better understand the biology of solid tumors in general, as well as targets for future therapeutics. In this review, we will summarize the current understanding of intestinal stem cell biology and translate it to colorectal CSCs to provide a basis for understanding chemoresistance, cancer recurrence and metastasis. A more complete understanding of the biology of colorectal CSCs will translate into the development of better chemotherapeutic and biological agents for the treatment of colorectal cancer.
机译:结直肠癌是美国癌症相关死亡率的第三大原因。正常肠道再生过程中涉及的复杂分子机制以及假定的体细胞肠道干细胞的特性已经很清楚。与此同时,实验证据已经出现,支持了一个古老的假设,即实体肿瘤的发生,发展,化学抗药性和复发是少数具有自我更新和多能能力的癌细胞的结果。这些“癌症干细胞”(CSC)提供了一个独特的机会,可以更好地了解实体瘤的生物学特性以及未来治疗的靶标。在这篇综述中,我们将总结当前对肠道干细胞生物学的理解,并将其转化为结直肠CSC,为理解化学耐药性,癌症复发和转移提供基础。对大肠CSC生物学的更完整理解将转化为更好的化学治疗和生物制剂的开发,以治疗大肠癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号